AVTR
Get informed when a big investor buys or sells
+ FollowOvervalued by 25.4% based on the discounted cash flow analysis.
| Market cap | $11.69 Billion |
|---|---|
| Enterprise Value | $11.42 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.78 |
| Beta | 0.94 |
| Outstanding Shares | 676,200,000 |
| P/E Ratio | -20.61 |
|---|---|
| PEG | 50.14 |
| Price to Sales | - |
| Price to Book Ratio | 2.16 |
| Enterprise Value to Revenue | 1283.65 |
| Enterprise Value to EBIT | -43.34 |
| Enterprise Value to Net Income | -20 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 83.98% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.46%▼ 103.80% |
|---|---|
| Total Invested | $46.35M▼ 99.34% |
| Investors Holding | 41▼ 429.00% |
No data
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.